Recent AMLX News
- Amylyx Pharmaceuticals Announces Publication of Data Showing the Encouraging Effects of AMX0035 on Cerebrospinal Fluid Biomarkers of Core Alzheimer’s Disease Pathology and Neurodegeneration • Business Wire • 08/12/2024 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 11:14:15 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 11:09:33 AM
- Amylyx Pharmaceuticals Reports Second Quarter 2024 Financial Results • Business Wire • 08/08/2024 11:00:00 AM
- Amylyx Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 8, 2024 • Business Wire • 08/05/2024 01:00:00 PM
- Amylyx Pharmaceuticals Receives Orphan Drug Designation From the European Commission for AMX0035 for the Treatment of Wolfram Syndrome • Business Wire • 08/02/2024 01:00:00 PM
- Kuehn Law Encourages Investors of Amylyx Pharmaceuticals, Inc. to Contact Law Firm • PR Newswire (US) • 07/18/2024 11:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2024 11:09:00 AM
- Amylyx Pharmaceuticals Announces Acquisition of Phase 3-ready GLP-1 Receptor Antagonist (Avexitide) with FDA Breakthrough Therapy Designation • Business Wire • 07/10/2024 11:00:00 AM
- Amylyx Pharmaceuticals to Host Conference Call to Discuss the Acquisition of Avexitide • Business Wire • 07/09/2024 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:52:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:50:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:49:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 08:07:30 PM
- Amylyx Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference • Business Wire • 06/04/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2024 11:36:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 11:12:01 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 11:05:38 AM
- Amylyx Pharmaceuticals Reports First Quarter 2024 Financial Results • Business Wire • 05/09/2024 11:00:00 AM
- Amylyx Pharmaceuticals to Present at the 2024 Bank of America Health Care Conference • Business Wire • 05/08/2024 01:00:00 PM
- Amylyx Pharmaceuticals to Report First Quarter 2024 Financial Results on May 9, 2024 • Business Wire • 05/02/2024 01:00:00 PM
- Amylyx Pharmaceuticals Announces Interim Data From Ongoing Phase 2 HELIOS Clinical Trial Demonstrating Improvements in Pancreatic Function and Glycemic Control with AMX0035 in People with Wolfram Syndrome • Business Wire • 04/10/2024 01:00:00 PM
- The Gross Law Firm Notifies Amylyx Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - AMLX • PR Newswire (US) • 04/09/2024 09:45:00 AM
- Amylyx Pharmaceuticals to Host Virtual Webcast to Discuss Interim Data from Phase 2 HELIOS Study of AMX0035 in Wolfram Syndrome on April 10, 2024 • Business Wire • 04/08/2024 01:00:00 PM
- Amylyx Pharmaceuticals, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - AMLX • PR Newswire (US) • 04/05/2024 09:45:00 AM
FEATURED Element79 Gold Corp Provides Update on Nevada Portfolio • Aug 23, 2024 8:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM